Abbott Healthcare Products B.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-06-23
Last Posted Date
2008-06-25
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
278
Registration Number
NCT00703482
Locations
🇦🇺

Site 003, Nedlands, Australia

🇦🇺

Site 002, Fremantle, Australia

🇦🇺

Site 001, Perth, Australia

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

First Posted Date
2008-06-23
Last Posted Date
2008-06-25
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
2288
Registration Number
NCT00703755
Locations
🇨🇦

Site 007, Chicoutimi, Canada

🇨🇦

Site 010, St. John's, Canada

🇨🇦

Site 004, Hamilton, Canada

and more 98 locations

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

First Posted Date
2008-06-05
Last Posted Date
2010-06-02
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
17
Registration Number
NCT00690820
Locations
🇺🇸

Site 10, Oklahoma City, Oklahoma, United States

🇺🇸

Site 2, Iowa City, Iowa, United States

🇺🇸

Site 5, Louisville, Kentucky, United States

and more 7 locations

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

First Posted Date
2008-03-25
Last Posted Date
2008-04-03
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
64
Registration Number
NCT00642512
Locations
🇺🇸

Site 943, Rancho Mirage, California, United States

🇺🇸

Site 922, Marietta, Georgia, United States

🇺🇸

Site 905, Southfield, Michigan, United States

and more 40 locations

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

First Posted Date
2008-03-25
Last Posted Date
2008-04-02
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
103
Registration Number
NCT00642499
Locations
🇺🇸

Site 914, Chicago, Illinois, United States

🇺🇸

Site 929, Sarasota, Florida, United States

🇺🇸

Site 952, Tallahassee, Florida, United States

and more 33 locations

Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

First Posted Date
2008-03-06
Last Posted Date
2009-08-06
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
56
Registration Number
NCT00630279
Locations
🇨🇿

Site 4205, Praha, Czech Republic

🇭🇺

Site 3606, Pecs, Hungary

🇵🇱

Site 4810, Gdansk, Poland

and more 47 locations

Effect of Omacor on Triglycerides in HIV Infected Subjects

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2008-01-23
Last Posted Date
2009-03-30
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
51
Registration Number
NCT00598910
Locations
🇩🇪

Site 2, Bochum, Germany

🇬🇧

Site 5, London, United Kingdom

🇩🇪

Site 1, Hannover, Germany

and more 2 locations

Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years

First Posted Date
2008-01-23
Last Posted Date
2008-06-30
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
120
Registration Number
NCT00599443

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Terminated
Conditions
First Posted Date
2007-12-05
Last Posted Date
2008-04-22
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
300
Registration Number
NCT00568009
Locations
🇺🇸

Site 90, Miami, Florida, United States

🇦🇷

Site 11, Bahia Blanca, Argentina

🇦🇷

Site 6, Coronel Suarez, Argentina

and more 69 locations

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

First Posted Date
2007-11-21
Last Posted Date
2008-10-27
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
400
Registration Number
NCT00562237
Locations
🇫🇮

Site 21, Helsinki, Finland

🇫🇮

Site 22, Tampere, Finland

🇫🇮

Site 23, Turku, Finland

and more 3 locations
© Copyright 2024. All Rights Reserved by MedPath